We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.85B
AUM Growth
+$101M
Cap. Flow
-$283M
Cap. Flow %
-15.29%
Top 10 Hldgs %
38.15%
Holding
96
New
12
Increased
21
Reduced
22
Closed
17

Top Sells

Rank Stock Value
1
LM
Legg Mason, Inc.
LM
+$27.8M
2
WFC icon
Wells Fargo
WFC
+$21.4M
3
C icon
Citigroup
C
+$15M
4
RDC
Rowan Companies Plc
RDC
+$14M
5
BRFS
BRF SA
BRFS
+$13.9M

Sector Composition

Rank Sector Weight
1 Healthcare 24.69%
2 Consumer Discretionary 11.93%
3 Financials 10.02%
4 Real Estate 6.3%
5 Energy 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHH
26
DELISTED
PHH Corporation
PHH
$20M 1.08%
870,659
+114,176
+15% +$2.71M
ANAC
27
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$20M 1.08%
1,126,039
-49,864
-4% -$803K
JPM icon
28
JPMorgan Chase
JPM
$939B
$19.8M 1.07%
343,770
-40,000
-10% -$2.25M
CYTR
29
DELISTED
CytRx Corp
CYTR
$19.3M 1.04%
769,983
-90,784
-11% -$2.07M
ASPS icon
30
PUT
Altisource Portfolio Solutions
ASPS
$65.4M
$19.1M 1.03%
20,838
+9,550
+85% +$8.52M
ALLY icon
31
Ally Financial
ALLY
$13.1B
$18.8M 1.02%
+800,375
New +$19.4M
QVCGA
32
DELISTED
QVC Group Inc Series A
QVCGA
$18.6M 1.01%
15,447
+7,151
+86% +$8.53M
CASC
33
DELISTED
Cascadian Therapeutics, Inc.
CASC
$18.2M 0.99%
938,150
AWI icon
34
Armstrong World Industries
AWI
$6.86B
$16.2M 0.88%
282,685
-14,900
-5% -$807K
TCOM icon
35
Trip.com Group
TCOM
$27.5B
$15.9M 0.86%
497,646
-300,354
-38% -$8.1M
TSM icon
36
PUT
TSMC
TSM
$2.09T
$15.2M 0.82%
711,300
BLUE
37
DELISTED
bluebird bio
BLUE
$14.1M 0.76%
28,302
+13,086
+86% +$4.2M
MDVN
38
DELISTED
MEDIVATION, INC.
MDVN
$12.9M 0.7%
335,456
-17,600
-5% -$593K
JKS
39
JinkoSolar
JKS
$775M
$10.8M 0.59%
+358,900
New +$9.8M
JASO
40
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$10.3M 0.56%
+951,900
New +$9.63M
AAPL icon
41
Apple
AAPL
$4.89T
$10.2M 0.55%
+439,200
New +$9.35M
FPRX
42
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$10M 0.54%
645,705
+344,199
+114% +$4.94M
ARMH
43
PUT
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$9.96M 0.54%
220,100
MRTX
44
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$9.95M 0.54%
507,184
-26,694
-5% -$515K
ZX
45
DELISTED
China Zenix Auto Internatl Ltd
ZX
$9.78M 0.53%
6,074,805
KERX
46
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$9.63M 0.52%
626,200
-209,000
-25% -$2.96M
ARRY
47
DELISTED
Array Biopharma Inc
ARRY
$9.56M 0.52%
2,096,200
-160,000
-7% -$662K
BCRX icon
48
BioCryst Pharmaceuticals
BCRX
$2.37B
$9.25M 0.5%
725,734
+200,000
+38% +$1.95M
XNCR icon
49
Xencor
XNCR
$1.44B
$9.23M 0.5%
794,600
-5,400
-0.7% -$53K
CLVS
50
DELISTED
Clovis Oncology, Inc.
CLVS
$8.69M 0.47%
209,735
-180,000
-46% -$9.27M

Similar funds

QVT Financial's Q2 2014 Portfolio in Review

As of Q2 2014, QVT Financial held 96 positions worth $1.85B, up 5.8% from $1.75B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

QVT Financial withdrew a net $283M in Q2 2014, closing 17 positions and reducing 22 holdings. Its most notable exit was Legg Mason, Inc., an estimated $27.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, QVT Financial opened a new position in MakeMyTrip worth $50.3M.

  • QVT Financial's largest Q2 2014 buy was MakeMyTrip: 1,431,000 shares worth $50.3M.
  • QVT Financial added most to Conn's Inc. in Q2 2014, an estimated $20.3M increase.
  • QVT Financial's biggest Q2 2014 reduction was BRF SA, cutting an estimated $13.9M.
  • QVT Financial fully exited Legg Mason, Inc. in Q2 2014, selling an estimated $27.8M.
  • QVT Financial's ten largest holdings make up 38% of its $1.85B portfolio in Q2 2014.
  • QVT Financial opened 12 new positions and closed 17 in Q2 2014.
  • QVT Financial's portfolio value rose 5.8% quarter-over-quarter to $1.85B.

Based on QVT Financial's 13F filing for Q2 2014, filed 14 Aug 2014.